HomeMarketThe Rocket Ph...

The Rocket Pharmaceuticals Inc. (RCKT) Stock expansion path ahead

Morgan Stanley raised the price target for the Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) stock to “an Overweight”. The rating was released on February 01, 2023, according to finviz.

The latest trade, Performances and Moving Averages give us the following Picture

The share price of Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) dipped -2.49% to close Friday’s market session at $23.45, lower as compared to yesterday’s close. The stock price fluctuated between $23.12 and $24.34 throughout the trading session with the volume trading being 2557490 shares, which represented a significant variation when compared to the three months average volume of 1.08 million shares. The firm’s stock price fluctuated 49.94% within the last five trades and 48.61% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 26.14% in the last 6 months and 3.08% was added to its value over the previous 3 months. RCKT stock is trading at a margin of 42.64%, 34.95% and 21.88% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


As of the close of trading, RCKT deals in the Healthcare domain. The stock is trading -4.87 percent below its 52-week high and 99.07 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is 17.7. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.

What Does Rocket Pharmaceuticals Inc.’s Profitability and Valuation Ratios Tell Us About the Stock?

The stock’s market cap achieved a total value of $2.12 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The firm managed a Price-to-Book ratio of 4.68, which equates the market value of a stock with its book value.

Is Insider Trading a Real Thing?

Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 3.76 percent of Rocket Pharmaceuticals Inc. shares are owned by insiders, and 89.70 percent are held by financial institutions. Shah Gaurav, the CEO at Rocket Pharmaceuticals Inc. (RCKT) has sold 4,767 shares of firm on Aug 17 at a price of $15.47 against the total amount of $73750.0. In another inside trade, Patel Kinnari, of Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) sold 1,534 shares of the firm on Aug 17 for a total worth of $23733.0 at a price of $15.47. An inside trade which took place on Aug 17, of Rocket Pharmaceuticals Inc. Militello John sold 284 shares of firm against total price of $4394.0 at the cost of $15.47 per share.



Please enter your comment!
Please enter your name here

Recent Post

It’s Better to Hope...

The idea of catching Chor...

It’s not the right ...